CoChat
Sign Up
Cited by 201

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism

Ren, Aileen A., Snellings, Daniel A., Su, Yourong S., Hong, Courtney C., Castro, Marco, Tang, Alan T., Detter, Matthew R., Hobson, Nicholas, Girard, Romuald, Romanos, Sharbel, Lightle, Rhonda, Moore, Thomas, Shenkar, Robert, Benavides, Christian, Beaman, M. Makenzie, Müller-Fielitz, Helge, Chen, Mei, Mericko, Patricia, Yang, Jisheng, Sung, Derek C., Lawton, Michael T., Ruppert, J. Michael, Schwaninger, Markus, Körbelin, Jakob, Potente, Michael, Awad, Issam A., Marchuk, Douglas A., Kahn, Mark L.·2021·Nature
DOI 10.1038/s41586-021-03562-8PMC PMC8626098
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-021-03562-8

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 45

  1. Cuttano, R. et al. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol. Med. 8, 6–24 (2015). · DOI
  2. Zhou, Z. et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 532, 122–126 (2016). · DOI
  3. Renz, M. et al. Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins. Dev. Cell 32, 181–190 (2015). · DOI
  4. Otten, C. et al. Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations. EMBO Mol. Med. 10, e9155 (2018). · DOI
  5. Fisher, O. S. & Boggon, T. J. Signaling pathways and the cerebral cavernous malformations proteins: lessons from structural biology. Cell. Mol. Life Sci. 71, 1881–1892 (2014). · DOI
  6. Plummer, N. W., Zawistowski, J. S. & Marchuk, D. A. Genetics of cerebral cavernous malformations. Curr. Neurol. Neurosci. Rep. 5, 391–396 (2005). · DOI
  7. Al-Shahi Salman, R. et al. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 11, 217–224 (2012). · DOI
  8. Awad, I. A. & Polster, S. P. Cavernous angiomas: deconstructing a neurosurgical disease. J. Neurosurg. 131, 1–13 (2019). · DOI
  9. Porter, P. J., Willinsky, R. A., Harper, W. & Wallace, M. C. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J. Neurosurg. 87, 190–197 (1997). · DOI
  10. Boulday, G. et al. Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice. J. Exp. Med. 208, 1835–1847 (2011). · DOI
  11. Detter, M. R., Snellings, D. A. & Marchuk, D. A. Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells. Circ. Res. 123, 1143–1151 (2018). · DOI
  12. Malinverno, M. et al. Endothelial cell clonal expansion in the development of cerebral cavernous malformations. Nat. Commun. 10, 2761 (2019). · DOI
  13. Ramírez-Zamora, A. & Biller, J. Brainstem cavernous malformations: a review with two case reports. Arq. Neuropsiquiatr. 67 (3B), 917–921 (2009). · DOI
  14. Castro, M. et al. CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression. Circ. Res. 124, 1240–1252 (2019). · DOI
  15. Hong, C. C. et al. Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican. J. Exp. Med. 217, e20200140 (2020). · DOI
  16. Lissbrant, I. F., Lissbrant, E., Persson, A., Damber, J. E. & Bergh, A. Endothelial cell proliferation in male reproductive organs of adult rat is high and regulated by testicular factors. Biol. Reprod. 68, 1107–1111 (2003). · DOI
  17. Rodriguez-Laguna, L. et al. Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly. J. Exp. Med. 216, 407–418 (2019). · DOI
  18. Castillo, S. D. et al. Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans. Sci. Transl. Med. 8, 332ra43 (2016). · DOI
  19. Castel, P. et al. Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci. Transl. Med. 8, 332ra42 (2016). · DOI
  20. Luks, V. L. et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J. Pediatr. 166, 1048–1054 (2015). · DOI
  21. Limaye, N. et al. Somatic activating PIK3CA mutations cuse venous malformation. Am. J. Hum. Genet. 97, 914–921 (2015). · DOI
  22. Rigamonti, D. et al. Cerebral cavernous malformations. Incidence and familial occurrence. N. Engl. J. Med. 319, 343–347 (1988). · DOI
  23. Dogruluk, T. et al. Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations. Cancer Res. 75, 5341–5354 (2015). · DOI
  24. Gault, J., Shenkar, R., Recksiek, P. & Awad, I. A. Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 36, 872–874 (2005). · DOI
  25. Akers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M. & Marchuk, D. A. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum. Mol. Genet. 18, 919–930 (2009). · DOI
  26. McDonald, D. A. et al. Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum. Mol. Genet. 23, 4357–4370 (2014). · DOI
  27. Xu, L. et al. Clonal evolution and changes in two AML patients detected with a novel single-cell DNA sequencing platform. Sci. Rep. 9, 11119 (2019). · DOI
  28. Lopez-Ramirez, M. A. et al. Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations. J. Exp. Med. 214, 3331–3346 (2017). · DOI
  29. Marchi, S. et al. Defective autophagy is a key feature of cerebral cavernous malformations. EMBO Mol. Med. 7, 1403–1417 (2015). · DOI
  30. Abdulrauf, S. I., Kaynar, M. Y. & Awad, I. A. A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 44, 41–46, discussion 46–47 (1999). · DOI
  31. Tan, W. H. et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J. Med. Genet. 44, 594–602 (2007). · DOI
  32. Adams, D. M. et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 137, e20153257 (2016). · DOI
  33. Ozeki, M. et al. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet J. Rare Dis. 14, 141 (2019). · DOI
  34. Triana, P. et al. Sirolimus in the treatment of vascular anomalies. Eur. J. Pediatr. Surg. 27, 86–90 (2017). · DOI
  35. Venot, Q. et al. Targeted therapy in patients with PIK3CA-related overgrowth syndrome. Nature 558, 540–546 (2018). · DOI
  36. Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483-486 (2010). · DOI
  37. Ridder, D. A. et al. TAK1 in brain endothelial cells mediates fever and lethargy. J. Exp. Med. 208, 2615–2623 (2011). · DOI
  38. Claxton, S. et al. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis 46, 74–80 (2008). · DOI
  39. Chan, A. C. et al. Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J. Clin. Invest. 121, 1871–1881 (2011). · DOI
  40. Foster, K. W. et al. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene 24, 1491–1500 (2005). · DOI
  41. Trotman, L. C. et al. Pten dose dictates cancer progression in the prostate. PLoS Biol. 1, E59 (2003). · DOI
  42. Adams, J. R. et al. Cooperation between Pik3ca and p53 mutations in mouse mammary tumor formation. Cancer Res. 71, 2706–2717 (2011). · DOI
  43. Körbelin, J. et al. A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases. EMBO Mol. Med. 8, 609–625 (2016). · DOI
  44. Hurst, C. D., Zuiverloon, T. C., Hafner, C., Zwarthoff, E. C. & Knowles, M. A. A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene. BMC Res. Notes 2, 66 (2009). · DOI
  45. Martelotto, L. G. ‘Frankenstein’ protocol for nuclei isolation from fresh and frozen tissue for snRNAseq. protocols.io https://doi.org/10.17504/protocols.io.3fkgjkw (2020). · DOI

Cited by

Sorted by citations

Metadata

Authors
Ren, A. A., Snellings, D. A., Su, Y. S., Hong, C. C., Castro, M., Tang, A. T., Detter, M. R., Hobson, N., Girard, R., Romanos, S., Lightle, R., Moore, T., Shenkar, R., Benavides, C., Beaman, M. M., Müller-Fielitz, H., Chen, M., Mericko, P., Yang, J., Sung, D. C., Lawton, M. T., Ruppert, J. M., Schwaninger, M., Körbelin, J., Potente, M., Awad, I. A., Marchuk, D. A., & Kahn, M. L.
Venue
Nature
Publisher
Springer Science and Business Media LLC
Published
2021-04-28
Volume
594
Issue
7862
Pages
271-276
ISSN
  • 0028-0836
  • 1476-4687
DOI
10.1038/s41586-021-03562-8
PMC
PMC8626098
Cited by
201
References
5
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review